Clinical trial / 2020
In a pilot study of postmenopausal women, consuming lycopene-rich tomato sauce prevented significant bone density loss compared to controls.
Researchers evaluated the in vitro effects of lycopene on Saos-2 osteoblast cells and conducted a pilot controlled trial assessing bone loss prevention via lycopene-rich tomato sauce in 39 postmenopausal women. In vitro, lycopene modulated Wnt/β-catenin, ERK 1/2, RUNX2, COL1A, and RANKL pathways. In the clinical trial, significant bone density loss was not detected in women consuming tomato sauce, whereas controls experienced bone loss (p = 0.002). Tomato sauce intake also led to a greater reduction in bone alkaline phosphatase compared with controls (18% vs 8.5%, p = 0.03).
- Study type
- In vitro study and pilot controlled clinical study
- Who was studied
- 39 postmenopausal women
- What was measured
- Bone mineral density and bone turnover markers
THE PAPER
Lycopene and bone: an in vitro investigation and a pilot prospective clinical study.
Russo C, Ferro Y, Maurotti S, Salvati MA, Mazza E, Pujia R, Terracciano R, Maggisano G, Mare R, Giannini S, Romeo S, Pujia A, Montalcini T. J Transl Med, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.